Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Lutathera

Lutathera 370 MBq/mL solution for infusion · Abschnitt 4.8 · PDF-Seite 14–15

HOS-135375 · Präparat HOS-097698

14 Gastrointestinal Nausea Abdominal distension Dry mouth disorders Vomiting Diarrhoea Flatulence Abdominal pain Ascites Constipation Gastrointestinal pain Abdominal pain upper Stomatitis Dyspepsia Haematochezia Gastritis Abdominal discomfort Intestinal obstruction Colitis Pancreatitis acute Rectal haemorrhage Melaena Abdominal pain lower Haematemesis Haemorrhagic ascites Ileus Hepatobiliary Hyperbilirubinaemia9 Pancreatic enzymes disorders decreased Hepatocellular injury Cholestasis Hepatic congestion Hepatic failure Skin and Alopecia Rash subcutaneous tissue Dry skin disorders Swelling face Hyperhidrosis Pruritus generalised Musculoskeletal and Musculoskeletal pain8 connective tissue Muscle spasms disorders Renal and urinary Acute kidney injury Leukocyturia disorders Haematuria Urinary incontinence Renal failure Glomerular filtration rate Proteinuria decreased Renal disorder Acute pre-renal failure Renal impairment General disorders and Fatigue1 Injection site reaction11 Injection site mass administration site Oedema peripheral Chest discomfort conditions Administration site pain Chest pain Chills Pyrexia Influenza-like illness Malaise Pain Death Feeling abnormal Investigations Blood creatinine increased Blood potassium decreased GGT* increased Blood urea increased ALT** increased Glycosylated haemoglobin AST*** increased increased Blood ALP**** increased Haematocrit decreased Protein urine Weight decreased Blood creatine phosphokinase increased Blood lactate dehydrogenase increased Blood catecholamines C-reactive protein increased Injury, poisoning and Clavicle fracture procedural complications

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.